This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Annamaria Calabro, MD; S. Eva Singletary, MD; Charles M. Balch, MD

Arch Surg. 1989;124(9):1051-1055.

Abstract
• The impact of nodal tumor burden on patterns of relapse and survival was retrospectively analyzed in 1001 patients with stage III melanoma. The incidence of tumor recurrence within the node dissection field was lower in patients with 1 nodal metastasis (9%) or with no extranodal invasion (15%) than in patients with multiple involved nodes (15% to 33%) or connective tissue invasion (28%). Patients with 1 "positive" node (a node in which cancer was detected) had a 45% 5-year and 39% 10-year survival rate compared with patients who had 2 to 4 positive nodes (37% and 28%), 5 to 10 nodes (20% and 17%), more than 10 nodes (5% and 3%), or extranodal invasion (14% and 11%). The occurrence of in-transit metastases in 10% of patients after nodal dissection was not influenced by the extent of nodal tumor burden.

(Arch Surg. 1989;124:1051-1055)

Author Affiliations
From the Department of General Surgery, The University of Texas M. D. Anderson Cancer Center, Houston.

Footnotes
Accepted for publication February 11, 1989.

Reprint requests to Department of General Surgery, Box 106, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Singletary).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel-Node Biopsy in Melanoma
Balch and Cascinelli
NEJM 2006;355:1370-1371.
FULL TEXT  

Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy
Pawlik et al.
Ann. Surg. Oncol. 2005;12:587-596.
ABSTRACT | FULL TEXT  

A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma
van Poll et al.
Ann. Surg. Oncol. 2005;12:597-608.
ABSTRACT | FULL TEXT  

The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
Pawlik et al.
JCO 2005;23:4588-4590.
FULL TEXT  

A Critical Assessment of Adjuvant Radiotherapy for Inguinal Lymph Node Metastases from Melanoma
Ballo et al.
Ann. Surg. Oncol. 2004;11:1079-1084.
ABSTRACT | FULL TEXT  

Lymphatic Mapping in the Molecular Era
Pawlik et al.
Ann. Surg. Oncol. 2004;11:362-374.
FULL TEXT  

Review and Evaluation of Sentinel Node Procedures in 250 Melanoma Patients With a Median Follow-Up of 6 Years
Estourgie et al.
Ann. Surg. Oncol. 2003;10:681-688.
ABSTRACT | FULL TEXT  

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Balch et al.
JCO 2001;19:3622-3634.
ABSTRACT | FULL TEXT  

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch et al.
JCO 2001;19:3635-3648.
ABSTRACT | FULL TEXT  

Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma
Pidhorecky et al.
Ann. Surg. Oncol. 2001;8:109-115.
ABSTRACT | FULL TEXT  

Minimal-Access Surgery for Staging of Malignant Melanoma
Krag et al.
Arch Surg 1995;130:654-658.
ABSTRACT